Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Holding EVFM?
Track your performance easily

Evofem Biosciences (EVFM) Financial Statements

1,217 Followers

Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently ―. The company's EPS TTM is $-0.787; its P/E ratio is -0.01; Evofem Biosciences is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Dec 22
Income Statement-
Total Revenue$ 4.16M$ 4.84M$ 5.11M$ 2.46M$ 181.00K
Gross Profit$ 3.39M$ 3.88M$ 3.22M$ 165.00K$ -203.00K
EBIT$ 1.91M$ -3.38M$ -3.55M$ -7.48M$ -9.98M
EBITDA$ 1.95M$ -2.05M$ -3.52M$ -7.31M$ -9.73M
Net Income Common Stockholders$ 1.30M$ -5.10M$ 66.00M$ -8.56M$ -11.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 636.00K$ 3.98M
Total Assets$ 8.55M$ 10.55M$ 13.32M$ 14.07M$ 25.16M
Total Debt$ 511.00K$ 43.37M$ 41.23M$ 43.20M$ 5.44M
Net Debt$ 511.00K$ 43.37M$ 41.23M$ 42.56M$ 1.47M
Total Liabilities$ 73.18M$ 77.06M$ 67.88M$ 69.74M$ 96.96M
Stockholders Equity$ -69.31M$ -66.51M$ -56.36M$ -55.66M$ -71.80M
Cash Flow-
Free Cash Flow$ -1.14M$ -170.00K$ -2.36M$ -1.50M$ -6.57M
Operating Cash Flow$ -1.14M$ -170.00K$ -2.36M$ -1.49M$ -6.53M
Investing Cash Flow---$ -1.00K$ -35.00K
Financing Cash Flow$ 1.14M$ 340.00K$ 2.14M$ 597.00K$ 1.50M
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis